International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
暂无分享,去创建一个
[1] B B Fredholm,et al. Neuroprotective role of adenosine in cerebral ischaemia. , 1992, Trends in pharmacological sciences.
[2] P. Fishman,et al. Adenosine acts as a chemoprotective agent by stimulating G‐CSF production: A role for A1 and A3 adenosine receptors , 2000, Journal of cellular physiology.
[3] B. Fredholm,et al. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. , 1999, Biochemical pharmacology.
[4] B. Mitchell,et al. Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] G. Ghai,et al. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. , 1989, Journal of Pharmacology and Experimental Therapeutics.
[6] J. Linden,et al. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. , 1999, Molecular pharmacology.
[7] Martin J. Lohse,et al. Crosstalk between Gαi- and Gαq-coupled receptors is mediated by Gβγ exchange , 1999 .
[8] S. Ferguson,et al. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.
[9] G. Lu,et al. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. , 1986, Molecular pharmacology.
[10] F. Northington,et al. Differential expression of A2a, A1-adenosine and D2-dopamine receptor genes in rat peripheral arterial chemoreceptors during postnatal development , 2000, Brain Research.
[11] C. Saunders,et al. Disruption of Microtubules Reveals Two Independent Apical Targeting Mechanisms for G-protein-coupled Receptors in Polarized Renal Epithelial Cells* , 1997, The Journal of Biological Chemistry.
[12] K. Klotz,et al. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. , 2000, Molecular pharmacology.
[13] Ying Chen,et al. Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo , 1992, British journal of pharmacology.
[14] B B Fredholm,et al. Adenosine actions and adenosine receptors after 1 week treatment with caffeine. , 1982, Acta physiologica Scandinavica.
[15] E. Jackson,et al. Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors. , 1998, Hypertension.
[16] B. Fredholm,et al. Dual effects of protein kinase-C on receptor-stimulated cAMP accumulation in a human T-cell leukemia line. , 1989, European journal of pharmacology.
[17] A. Tucker,et al. A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. , 1994, The Journal of biological chemistry.
[18] Akinori Kidera,et al. Surface of bacteriorhodopsin revealed by high-resolution electron crystallography , 1997, Nature.
[19] S. Mundell,et al. Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells. , 1998, Biochemical pharmacology.
[20] M. Curtis. Pharmacologic analysis of drug-receptor interaction (2nd edition)Edited by T Kenakin. (Pp 468; $113.50.) New York: Reven Press, 1993. ISBN 0-7817-0065-5 , 1995 .
[21] B. Fredholm,et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[22] G Burnstock,et al. Towards a revised nomenclature for P1 and P2 receptors. , 1997, Trends in pharmacological sciences.
[23] J. Mackey,et al. Nucleoside transporters: molecular biology and implications for therapeutic development. , 1999, Molecular medicine today.
[24] K. Jacobson,et al. Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor. , 1992, Drug design and discovery.
[25] A. Czernik,et al. Antibodies to an epitope on synapsin I detect a protein associated with the endocytic compartment in non-neuronal cells. , 1994, European journal of cell biology.
[26] B. Fredholm,et al. Alpha-adrenoceptor stimulation, but not muscarinic stimulation, increases cyclic AMP accumulation in brain slices due to protein kinase C mediated enhancement of adenosine receptor effects. , 1987, Acta physiologica Scandinavica.
[27] T. Kenakin,et al. Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. , 1995, Trends in pharmacological sciences.
[28] S. Rivkees,et al. Identification of the Adenine Binding Site of the Human A1 Adenosine Receptor* , 1999, The Journal of Biological Chemistry.
[29] K. Klotz,et al. Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists. , 2000, Journal of medicinal chemistry.
[30] V. Sexl,et al. Stimulation of the Mitogen-activated Protein Kinase via the A2A-Adenosine Receptor in Primary Human Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[31] M. Beal,et al. 2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicity , 1991, Neuroscience Letters.
[32] G. Lozza,et al. Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist. , 2000, European journal of pharmacology.
[33] J. Neary,et al. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures , 1998, Neuroscience Letters.
[34] J. Deckert,et al. Adenosine--an endogenous neuroprotective metabolite and neuromodulator. , 1994, Journal of neural transmission. Supplementum.
[35] E. Ongini,et al. 2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. , 1995, Journal of medicinal chemistry.
[36] T. White,et al. A comparison of N-methyl-D-aspartate-evoked release of adenosine and [3H]norepinephrine from rat cortical slices. , 1990, The Journal of pharmacology and experimental therapeutics.
[37] B. Fredholm,et al. Adenosine A1 receptor agonism in the immature rat brain and heart , 2001 .
[38] G Burnstock,et al. Nomenclature and Classification of Purinoceptors* , 2005 .
[39] L. Belardinelli,et al. Differential A1‐adenosine receptor reserve for inhibition of cyclic AMP accumulation and G‐protein activation in DDT1 MF‐2 cells , 2000, British journal of pharmacology.
[40] J. Gusella,et al. Mapping of a human A2a adenosine receptor (ADORA2) to chromosome 22. , 1994, Genomics.
[41] R. F. Bruns,et al. Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts. , 1981, Biochemical pharmacology.
[42] B B Fredholm,et al. ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. , 1992, The Journal of biological chemistry.
[43] J. Linden,et al. A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. , 2000, American journal of physiology. Renal physiology.
[44] J. Girault,et al. Gαolf is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum , 2001, Journal of neurochemistry.
[45] J. Baldwin,et al. Arrangement of rhodopsin transmembrane alpha-helices. , 1997, Nature.
[46] I. Biaggioni,et al. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. , 1995, The Journal of clinical investigation.
[47] T. Palmer,et al. Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A(3) adenosine receptor. , 2000, Molecular pharmacology.
[48] M. Low,et al. Functional Uncoupling of Adenosine A2A Receptors and Reduced Response to Caffeine in Mice Lacking Dopamine D2Receptors , 2000, The Journal of Neuroscience.
[49] B. Fredholm,et al. Release of Adenosine from Rat Hippocampal Slices by Nitric Oxide Donors , 1996, Journal of neurochemistry.
[50] S. Rivkees,et al. Adenosine A1 receptors are located predominantly on axons in the rat hippocampal formation , 1995, The Journal of comparative neurology.
[51] M. Morelli,et al. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6‐hydroxydopamine‐lesioned rats , 2001, Synapse.
[52] B. Fredholm,et al. CD3/T‐cell receptor coupling to a pertussis and cholera toxin‐insensitive G‐protein , 1989, FEBS letters.
[53] G. Stiles,et al. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Dickenson,et al. Involvement of G-protein βγ subunits in coupling the adenosine A1 receptor to phospholipase C in transfected CHO cells , 1998 .
[55] Per Svenningsson,et al. GTP differentially affects antagonist radioligand binding to adenosine A1 and A2A receptors in human brain , 2000, Neuropharmacology.
[56] H Luecke,et al. Structure of bacteriorhodopsin at 1.55 A resolution. , 1999, Journal of molecular biology.
[57] P. Svenningsson,et al. Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine. , 1996, Life sciences.
[58] K. Klotz,et al. 2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors. , 1992, Journal of medicinal chemistry.
[59] J. Linden,et al. Design, synthesis, and evaluation of novel A2A adenosine receptor agonists. , 2001, Journal of medicinal chemistry.
[60] I. Biaggioni,et al. Role of p 38 Mitogen-Activated Protein Kinase and Extracellular Signal-Regulated Protein Kinase Kinase in Adenosine A 2 B Receptor-Mediated Interleukin-8 Production in Human Mast Cells , 1999 .
[61] G. Stiles,et al. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. , 1993, The Journal of biological chemistry.
[62] Y. Chern,et al. Characterization of the rat A2a adenosine receptor gene. , 1996, DNA and cell biology.
[63] H. Mcilwain,et al. Metabolism of ( 14 C)adenine and derivatives by cerebral tissues, superfused and electrically stimulated. , 1972, The Biochemical journal.
[64] Y. Chern,et al. Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A. , 1995, Molecular pharmacology.
[65] L. Thim,et al. Adenosine is an agonist of the growth hormone secretagogue receptor. , 2000, Endocrinology.
[66] T. Palmer,et al. Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. , 1997, Biochemistry.
[67] Sergi Ferré,et al. Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.
[68] K. Jacobson,et al. Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats. , 1996, European journal of pharmacology.
[69] K. Jacobson,et al. Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation. , 2000, Biochemical pharmacology.
[70] M. Poo,et al. Binding of DCC by Netrin-1 to Mediate Axon Guidance Independent of Adenosine A2B Receptor Activation , 2001, Science.
[71] J. Gutkind. The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.
[72] A. IJzerman,et al. Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine. , 2000, Molecular pharmacology.
[73] T. Palmer,et al. Molecular Basis for Subtype-specific Desensitization of Inhibitory Adenosine Receptors , 1996, The Journal of Biological Chemistry.
[74] T. Palmer,et al. Differential Interaction with and Regulation of Multiple G-proteins by the Rat A3 Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.
[75] Beverly H. Koller,et al. Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells* , 2000, The Journal of Biological Chemistry.
[76] M. Parmentier,et al. The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. , 1991, The EMBO journal.
[77] A. Graybiel,et al. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. , 1992, Journal of neurophysiology.
[78] H. Bourne,et al. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. , 1994, The Journal of biological chemistry.
[79] S. Schiffmann,et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.
[80] J Hoflack,et al. Re-evaluation of bacteriorhodopsin as a model for G protein-coupled receptors. , 1994, Trends in pharmacological sciences.
[81] B B Fredholm,et al. Xanthine derivatives as adenosine receptor antagonists. , 1982, European journal of pharmacology.
[82] B. Fredholm. Effect of adenosine, adenosine analogues and drugs inhibiting adenosine inactivation on lipolysis in rat fat cells. , 1978, Acta physiologica Scandinavica.
[83] G. Cristalli,et al. Adenosine receptor agonists: synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA. , 1997, Bioorganic & medicinal chemistry.
[84] J. Mallol,et al. Adenosine Deaminase and A1 Adenosine Receptors Internalize Together following Agonist-induced Receptor Desensitization* , 1998, The Journal of Biological Chemistry.
[85] P. Greengard,et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[86] J. Geiger,et al. Levels of endogenous adenosine in rat striatum. I. Regulation by ionotropic glutamate receptors, nitric oxide and free radicals. , 1998, The Journal of pharmacology and experimental therapeutics.
[87] P. Schofield,et al. A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding. , 1994, The Journal of biological chemistry.
[88] M. Simon,et al. G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. , 1995, The Journal of biological chemistry.
[89] M. Freissmuth,et al. Activation of Mitogen-activated Protein Kinase by the A2A-adenosine Receptor via a rap1-dependent and via a p21 ras -dependent Pathway* , 1999, The Journal of Biological Chemistry.
[90] H Zimmermann,et al. New insights into molecular structure and function of ectonucleotidases in the nervous system. , 1998, Neurochemistry international.
[91] A. Mendonça,et al. Adenosine inhibits the NMDA receptor-mediated excitatory postsynaptic potential in the hippocampus , 1993, Brain Research.
[92] B. Fredholm,et al. Activation of protein kinase C inhibits prostaglandin‐ and potentiates adenosine receptor‐stimulated accumulation of cyclic AMP in a human T‐cell leukemia line , 1987, FEBS letters.
[93] G. Milligan,et al. Down-regulation of Gi sub-types by prolonged incubation of adipocytes with an A1 adenosine receptor agonist. , 1990, The Journal of biological chemistry.
[94] P. Greengard,et al. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons , 1998, Neuroscience.
[95] A. Dana,et al. Adenosine A1 Receptor Activation Induces Delayed Preconditioning in Rats Mediated by Manganese Superoxide Dismutase , 2000 .
[96] M. Simon,et al. Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C (*) , 1995, The Journal of Biological Chemistry.
[97] H. Sato,et al. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. , 1997, The Journal of pharmacology and experimental therapeutics.
[98] A. Chédotal,et al. Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor , 2000, Nature.
[99] P. Svenningsson,et al. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons , 1999, Neuroscience.
[100] C. Myung,et al. Phosphorylation of the G protein gamma12 subunit regulates effector specificity. , 1998, The Journal of biological chemistry.
[101] B. Fredholm. Purines and neutrophil leukocytes. , 1997, General pharmacology.
[102] K. Jacobson,et al. [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[103] B. Fredholm,et al. Propentofylline and Other Adenosine Transport Inhibitors Increase the Efflux of Adenosine Following Electrical or Metabolic Stimulation of Rat Hippocampal Slices , 1994, Journal of neurochemistry.
[104] S. Snyder,et al. Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[105] W SLEATOR,et al. EFFECTS OF CAFFEINE ON MAMMALIAN ATRIAL MUSCLE, AND ITS INTERACTION WITH ADENOSINE AND CALCIUM. , 1965, The Journal of pharmacology and experimental therapeutics.
[106] B. Fredholm,et al. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography , 1995, Neuropharmacology.
[107] W. Meyerhof,et al. Molecular cloning of a novel putative G‐protein coupled receptor expressed during rat spermiogenesis , 1991, FEBS letters.
[108] D. Cooper,et al. Subclasses of external adenosine receptors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[109] Xiaowei Jin,et al. Molecular characterization of recombinant human adenosine receptors , 1996 .
[110] B. Fredholm,et al. Glucocorticoid receptor activation leads to up-regulation of adenosine A1 receptors and down-regulation of adenosine A2 responses in DDT1 MF-2 smooth muscle cells. , 1991, Molecular pharmacology.
[111] A. Składanowski,et al. The Mechanism of Adenosine Formation in Cells , 1999, The Journal of Biological Chemistry.
[112] B. Fredholm,et al. Pharmacology of adenosine A2A receptors. , 1996, Trends in pharmacological sciences.
[113] V. Thourani,et al. A3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. , 1999, American journal of physiology. Heart and circulatory physiology.
[114] A. IJzerman,et al. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds. , 1998, Journal of medicinal chemistry.
[115] P. Greengard,et al. The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[116] B. Fredholm,et al. Down-regulation of adenosine A2A receptors upon NGF-induced differentiation of PC12 cells , 1997, Neuropharmacology.
[117] J. Dickenson,et al. Involvement of G-protein betagamma subunits in coupling the adenosine A1 receptor to phospholipase C in transfected CHO cells. , 1998, European journal of pharmacology.
[118] C. Franceschi,et al. Modulation of Apoptosis by Adenosine in the Central Nervous System: a Possible Role for the A3 Receptor , 1997, Annals of the New York Academy of Sciences.
[119] K. Jacobson,et al. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. , 2000, Journal of medicinal chemistry.
[120] Liping Huang,et al. Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. , 1999, American journal of physiology. Renal physiology.
[121] E. Jackson,et al. A 2 B Receptors Mediate Antimitogenesis in Vascular Smooth Muscle Cells , 2000 .
[122] G. Burnstock. A basis for distinguishing two types of purinergic receptor , 1978 .
[123] A. Balmforth,et al. Adenosine receptor-induced cAMP changes in D384 astrocytoma cells and the effect of bradykinin thereon. , 1992, Acta physiologica Scandinavica.
[124] T. Gudermann,et al. Functional and structural complexity of signal transduction via G-protein-coupled receptors. , 1997, Annual review of neuroscience.
[125] K. Jacobson,et al. 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors. , 1994, Journal of medicinal chemistry.
[126] S. Schiffmann,et al. Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.
[127] K. Fuxe,et al. Postsynaptic antagonistic interaction between adenosine A1, and dopamine D1 receptors , 1994, Neuroreport.
[128] P. Jenner,et al. Combined Use of the Adenosine A2A Antagonist KW-6002 with l -DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys , 2000, Experimental Neurology.
[129] F. Ciruela,et al. Adenosine Deaminase Interacts with A1 Adenosine Receptors in Pig Brain Cortical Membranes , 1996, Journal of neurochemistry.
[130] Gebhard F. X. Schertler,et al. Arrangement of rhodopsin transmembrane α-helices , 1997, Nature.
[131] P. Schofield,et al. Characterization and chromosomal localization of the human A2a adenosine receptor gene: ADORA2A. , 1996, Biochemical and biophysical research communications.
[132] K. Jacobson,et al. Site-directed mutagenesis of the human adenosine A2A receptor. Critical involvement of Glu13 in agonist recognition. , 1996, European journal of pharmacology.
[133] K. Klotz,et al. Photoaffinity labeling of A1-adenosine receptors. , 1985, The Journal of biological chemistry.
[134] K. Jacobson,et al. Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors. , 1999, Drug design and discovery.
[135] L. Conforti,et al. Chronic hypoxia reduces adenosine A2A receptor‐mediated inhibition of calcium current in rat PC12 cells via downregulation of protein kinase A , 1998, The Journal of physiology.
[136] B. Fredholm,et al. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[137] J. F. Chen,et al. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[138] Marc Parmentier,et al. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A2A receptors , 2000, British journal of pharmacology.
[139] L. Limbird,et al. Trafficking itineraries of G protein-coupled receptors in epithelial cells do not predict receptor localization in neurons , 1998, Brain Research.
[140] M. Danhof,et al. Selectivity of action of 8‐alkylamino analogues of N6‐cyclopentyladenosine in vivo: haemodynamic versus anti‐lipolytic responses in rats , 1998, British journal of pharmacology.
[141] D. Cooper,et al. Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[142] B. Fredholm,et al. Stimulatory and inhibitory effects of adenosine A2A receptors on nerve growth factor-induced phosphorylation of extracellular regulated kinases 1/2 in PC12 cells , 2000, Neuroscience Letters.
[143] P. Svenningsson,et al. The Stimulatory Action and the Development of Tolerance to Caffeine Is Associated with Alterations in Gene Expression in Specific Brain Regions , 1999, The Journal of Neuroscience.
[144] B. Fredholm,et al. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices , 1995, Neurochemistry International.
[145] J. Linden,et al. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. , 1997, Molecular pharmacology.
[146] F. Northington,et al. Differential expression of a(2a), A(1)-adenosine and D(2)-dopamine receptor genes in rat peripheral arterial chemoreceptors during postnatal development. , 2000, Brain research.
[147] K. Jacobson,et al. A binding site model and structure-activity relationships for the rat A3 adenosine receptor. , 1994, Molecular pharmacology.
[148] B. Fredholm. Adenosine and neuroprotection. , 1997, International review of neurobiology.
[149] C. Gerfen,et al. D1 dopamine receptor‐mediated induction of zif268 and c‐fos in the dopamine‐depleted striatum: Differential regulation and independence from NMDA receptors , 1996, The Journal of comparative neurology.
[150] A. Morice,et al. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. , 1983, British journal of clinical pharmacology.
[151] M. Lohse,et al. Crosstalk between Galpha(i)- and Galpha(q)-coupled receptors is mediated by Gbetagamma exchange. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[152] J. Geiger,et al. Levels of endogenous adenosine in rat striatum. II. Regulation of basal and N-methyl-D-aspartate-induced levels by inhibitors of adenosine transport and metabolism. , 1998, The Journal of pharmacology and experimental therapeutics.
[153] W. Schütz,et al. Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding. , 1991, The Biochemical journal.
[154] O. Barnabei,et al. Adenosine and Glutamate Modulate Each Other's Release from Rat Hippocampal Synaptosomes , 1991, Journal of neurochemistry.
[155] A. IJzerman,et al. Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding. , 1996, Molecular pharmacology.
[156] J. Linden,et al. Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system , 1998, The Journal of comparative neurology.
[157] B. Fredholm,et al. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion , 1993, Neurochemistry International.
[158] R. J. Hill,et al. Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors. , 1997, The Journal of pharmacology and experimental therapeutics.
[159] B. Fredholm,et al. Adenosine and brain ischemia. , 1992, Cerebrovascular and brain metabolism reviews.
[160] Kenneth A Jacobson,et al. Molecular architecture of G protein‐coupled receptors , 1996, Drug development research.
[161] J. Wess,et al. Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.
[162] M. Leid,et al. Cyclopentyladenosine‐Induced Homologous Down‐Regulation of A1 Adenosine Receptors (A1AR) in Intact Neurons Is Accompanied by Receptor Sequestration but Not a Reduction in A1AR mRNA Expression or G Protein α‐Subunit Content , 1998, Journal of neurochemistry.
[163] S. Rivkees,et al. Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. , 1992, Molecular endocrinology.
[164] J. Linden,et al. Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonists , 2001 .
[165] P. Svenningsson,et al. Distribution, biochemistry and function of striatal adenosine A2A receptors , 1999, Progress in Neurobiology.
[166] J. Linden. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. , 1994, Trends in pharmacological sciences.
[167] J. Linden,et al. Molecular cloning and characterization of the human A3 adenosine receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[168] A. IJzerman,et al. 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor. , 1998, Journal of medicinal chemistry.
[169] R. Nicoll,et al. Release of adenosine by activation of NMDA receptors in the hippocampus. , 1994, Science.
[170] B. Fredholm,et al. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[171] J. Fozard,et al. Mast cell degranulation following adenosine A3 receptor activation in rats. , 1996, European journal of pharmacology.
[172] M. Low,et al. The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice , 2001 .
[173] P. Narayan,et al. Activated Cardiac Adenosine A1 Receptors Translocate Out of Caveolae* , 2000, The Journal of Biological Chemistry.
[174] B. Fredholm,et al. Release of Purines, Noradrenaline, and GABA from Rat Hippocampal Slices by Field Stimulation , 1985, Journal of neurochemistry.
[175] T. Dunwiddie,et al. Adenine Nucleotides Undergo Rapid, Quantitative Conversion to Adenosine in the Extracellular Space in Rat Hippocampus , 1997, The Journal of Neuroscience.
[176] J. Linden,et al. Design, synthesis, and evaluation of novel adenosine A2A receptor agonists , 2000 .
[177] Y. Chern,et al. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. , 1993, Molecular pharmacology.
[178] E. Jackson,et al. A(2B) receptors mediate antimitogenesis in vascular smooth muscle cells. , 2000, Hypertension.
[179] R. Henderson,et al. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.
[180] R. K. Shepherd,et al. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. , 1997, The Journal of clinical investigation.
[181] M. Jacobson,et al. Cloning and chromosomal localization of the human A2b adenosine receptor gene (ADORA2B) and its pseudogene. , 1995, Genomics.
[182] T J Furlong,et al. Molecular characterization of a human brain adenosine A2 receptor. , 1992, Brain research. Molecular brain research.
[183] H Zimmermann,et al. New insights into molecular structure and function of ecto-nucleotidases in the nervous system , 1998, Neurochemistry International.
[184] M. Lindorfer,et al. Role of the Prenyl Group on the G Protein γ Subunit in Coupling Trimeric G Proteins to A1 Adenosine Receptors* , 1996, The Journal of Biological Chemistry.
[185] P. Schofield,et al. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors. , 1998, Biochemical pharmacology.
[186] B. Fredholm. Chapter 11 Adenosine and Neuroprotection , 1996 .
[187] S. Hyman,et al. Amphetamine and Dopamine-Induced Immediate Early Gene Expression in Striatal Neurons Depends on Postsynaptic NMDA Receptors and Calcium , 1996, The Journal of Neuroscience.
[188] Stefano Manfredini,et al. Synthesis of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c] pyrimidine and 1,2,3-triazolo[4,5-e]1,2,4-triazolo[1,5-c] pyrimidine displaying potent and selective activity as A2a adenosine receptor antagonists. , 1994 .
[189] A. Pomés,et al. Adenosine: A partial agonist of the growth hormone secretagogue receptor. , 2000, Biochemical and biophysical research communications.
[190] A. Multani,et al. Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor. , 2000, European journal of cancer.
[191] E. Newsholme,et al. The control of the metabolism and the hormonal role of adenosine. , 1978, Essays in biochemistry.
[192] Terrence P. Kenakin,et al. A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .
[193] S Schiffmann,et al. RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. , 1990, Biochemical and biophysical research communications.
[194] K. Jacobson,et al. 1,3‐dialkylxanthine derivatives having high potency as antagonists at human A2B adenosine receptors , 1999, Drug development research.
[195] R. Peterfreund,et al. Agonist-induced desensitization of A2B adenosine receptors. , 1998, Biochemical pharmacology.
[196] A. Tucker,et al. Dominance of G(s) in doubly G(s)/G(i)-coupled chimaeric A(1)/A(2A) adenosine receptors in HEK-293 cells. , 2000, The Biochemical journal.
[197] J. Wess,et al. Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition. , 1996, Molecular pharmacology.
[198] T. Dunwiddie,et al. Modulation of Excitatory Synaptic Transmission by Adenosine Released from Single Hippocampal Pyramidal Neurons , 1996, The Journal of Neuroscience.
[199] A. Bonci,et al. A Common Mechanism Mediates Long-Term Changes in Synaptic Transmission after Chronic Cocaine and Morphine , 1996, Neuron.
[200] J. Gusella,et al. Characterization and Expression of the Human A2a Adenosine Receptor Gene , 1996, Journal of neurochemistry.
[201] B B Fredholm,et al. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[202] B. Fredholm,et al. Maternal Caffeine Intake Has Minor Effects on Adenosine Receptor Ontogeny in the Rat Brain , 2000, Pediatric Research.
[203] G. Stiles,et al. Dexamethasone stimulates human A1 adenosine receptor (A1AR) gene expression through multiple regulatory sites in promoter B. , 1999, Molecular pharmacology.
[204] K. Jacobson,et al. Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor. , 1994, European journal of pharmacology.
[205] H. Gavras,et al. A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. , 2000, Biochimica et biophysica acta.
[206] G. Stiles,et al. The role of receptor structure in determining adenosine receptor activity. , 2000, Pharmacology & therapeutics.
[207] Margarete Müller,et al. Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells , 1978, Nature.
[208] Tianxin Yang,et al. Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[209] J. Keefer,et al. Receptors Coupled to Pertussis Toxin-sensitive G-proteins Traffic to Opposite Surfaces in Madin-Darby Canine Kidney Cells , 1996, The Journal of Biological Chemistry.
[210] H. Haas,et al. Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats , 1996, Neuroscience.
[211] N. Veldman,et al. N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors. , 1996, Journal of medicinal chemistry.
[212] A. Bridges,et al. N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor. , 1988, Journal of medicinal chemistry.
[213] R. McCarley,et al. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. , 1997, Science.
[214] A. IJzerman,et al. Processing of adenosine receptor agonists in rat and human whole blood. , 1998, Biochemical pharmacology.
[215] D. Dewitt,et al. Cloning of an adenosine A1 receptor-encoding gene from rabbit. , 1993, Gene.
[216] P. Ueland,et al. Regional and Subcellular Distribution of S‐Adenosylhomocysteine Hydrolase in the Adult Rat Brain , 1980, Journal of neurochemistry.
[217] S. Butcher,et al. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists , 1997, British journal of pharmacology.
[218] J. Wess,et al. Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition. , 1996, Molecular pharmacology.
[219] R. Corradetti,et al. Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices , 1999, British journal of pharmacology.
[220] B. Fredholm,et al. Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[221] B. Fredholm,et al. Bradykinin inhibits cyclic AMP accumulation in D384-human astrocytoma cells via a calcium-dependent inhibition of adenylyl cyclase. , 1993, Cellular signalling.
[222] K. Fuxe,et al. Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic , 1997, Neuropsychopharmacology.
[223] E. Ongini,et al. Adenosine receptors in neurological disorders , 2000 .
[224] B. Fredholm,et al. Adenosine A(1) receptor agonism in the immature rat brain and heart. , 2001, European journal of pharmacology.
[225] J. Shine,et al. Molecular cloning and expression of an adenosine A2b receptor from human brain. , 1992, Biochemical and biophysical research communications.
[226] G. Stiles,et al. Solubilization and characterization of the A2-adenosine receptor. , 1993, Journal of receptor research.
[227] L. Storstein,et al. Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma. , 1990, The European respiratory journal.
[228] J. Schrader,et al. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. , 1997, Circulation research.
[229] G Vassart,et al. Selective amplification and cloning of four new members of the G protein-coupled receptor family. , 1989, Science.
[230] J. Fergus,et al. Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes. , 1990, Molecular pharmacology.
[231] P. Singh,et al. The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist , 1995, British journal of pharmacology.
[232] A. Strosberg,et al. Species difference in the G protein selectivity of the human and bovine A1-adenosine receptor. , 1994, The Journal of biological chemistry.
[233] E. Jackson,et al. Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. , 1996, Hypertension.
[234] P. Babál,et al. 5-( N-ethylcarboxamido)adenosine desensitizes the A2b-adenosine receptor in lung circulation. , 1999, American journal of physiology. Heart and circulatory physiology.
[235] G. Stiles,et al. Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing. , 1994, The Journal of biological chemistry.
[236] B. Fredholm,et al. Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMP , 1992, Neurochemistry International.
[237] A. Clerk,et al. Regulation of mitogen-activated protein kinase cascades in the heart. , 1998, Advances in enzyme regulation.
[238] J Hoflack,et al. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.
[239] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[240] K. Jacobson,et al. Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells. , 1991, Molecular pharmacology.
[241] U. Ungerstedt,et al. Striatal adenosine levels measured ‘in vivo’ by microdialysis in rats with unilateral dopamine denervation , 1987, Neuroscience Letters.
[242] S. Moro,et al. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. , 1999, Journal of medicinal chemistry.
[243] Margarete Müller,et al. ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS , 1979, Journal of neurochemistry.
[244] R. Mentzer,et al. Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart. , 1990, Journal of molecular and cellular cardiology.
[245] S. Ferré,et al. Stimulation of adenosine A1 receptors prevents the EEG arousal due to dopamine D1 receptor activation in rabbits. , 1996, European journal of pharmacology.
[246] J. Benovic,et al. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.
[247] B. Fredholm,et al. Adenosine receptor‐mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells , 1985, Journal of cellular physiology.
[248] R. Lefkowitz,et al. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. , 1999, Current opinion in cell biology.
[249] T. Williams,et al. Multiple sodium-dependent nucleoside transport systems in bovine renal brush-border membrane vesicles. , 1991, The Biochemical journal.
[250] C. Cass,et al. Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/nucleoside cotransporters in rat brain. , 1996, Brain research. Molecular brain research.
[251] M. Danhof,et al. Deoxyribose analogues of N6‐cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo , 1995, British journal of pharmacology.
[252] W. McIntire,et al. The G Protein β Subunit Is a Determinant in the Coupling of Gs to the β1-Adrenergic and A2a Adenosine Receptors* , 2001, The Journal of Biological Chemistry.
[253] M. Moskowitz,et al. A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice , 1999, The Journal of Neuroscience.
[254] A. Szent-Györgyi,et al. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart 1 , 1929, The Journal of physiology.
[255] X.-T. Hu,et al. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[256] A. IJzerman,et al. Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding. , 1999, Journal of medicinal chemistry.
[257] X. Ji,et al. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists. , 1994, Journal of medicinal chemistry.
[258] P. Svenningsson,et al. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[259] A. IJzerman,et al. Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor. , 2000, Journal of medicinal chemistry.
[260] A. Tucker,et al. Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution. , 1993, Molecular pharmacology.
[261] H. Prast,et al. Adenosine release in the ventral striatum of the rat is modulated by endogenous nitric oxide. , 1995, European journal of pharmacology.
[262] D. Scholl,et al. Serine and alanine mutagenesis of the nine native cysteine residues of the human A(1) adenosine receptor. , 2000, Biochemical pharmacology.
[263] B. Fredholm,et al. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. , 2001, Biochemical pharmacology.
[264] I. Biaggioni,et al. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. , 1999, Molecular pharmacology.
[265] J. Blank,et al. Human adenosine A1 receptor and P2Y2‐purinoceptor‐mediated activation of the mitogen‐activated protein kinase cascade in transfected CHO cells , 1998, British journal of pharmacology.
[266] G. Firestein,et al. cDNA cloning and sequence analysis of the human A3 adenosine receptor. , 1993, Biochimica et biophysica acta.
[267] K. Jacobson,et al. Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. , 1992, The Journal of biological chemistry.
[268] R. Peterfreund,et al. Protein kinase C regulates adenosine A2a receptor mRNA expression in SH-SY5Y cells. , 1997, European journal of pharmacology.
[269] A. Townsend-Nicholson,et al. Molecular cloning and characterisation of a human brain A1 adenosine receptor cDNA. , 1992, Brain research. Molecular brain research.
[270] T. Dunwiddie,et al. Regulation of extracellular adenosine in rat hippocampal slices is temperature dependent: role of adenosine transporters , 1999, Neuroscience.
[271] Leo Dorst,et al. Differential A* , 2002, IEEE Trans. Knowl. Data Eng..
[272] C. Myung,et al. Phosphorylation of the G Protein γ12 Subunit Regulates Effector Specificity* , 1998, The Journal of Biological Chemistry.
[273] J. Daly,et al. Structure-activity relationships for N6-substituted adenosines at a brain A1-adenosine receptor with a comparison to an A2-adenosine receptor regulating coronary blood flow. , 1986, Biochemical pharmacology.
[274] E. Krebs,et al. The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[275] G. Stiles,et al. Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs. , 1989, Molecular pharmacology.
[276] R. Berne,et al. Release of Adenosine from Ischemic Brain: Effect on Cerebral Vascular Resistance and Incorporation into Cerebral Adenine Nucleotides , 1974 .
[277] P. Svenningsson,et al. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas , 1997, Neuroscience.
[278] A. Bridges,et al. N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor. , 1989, Journal of medicinal chemistry.
[279] G. Spalluto,et al. A3 Adenosine Receptor Ligands: History and Perspectives , 2000, Medicinal research reviews.
[280] P. Greengard,et al. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices , 1990, Nature.
[281] Y. Wong,et al. Preactivation permits subsequent stimulation of phospholipase C by G(i)-coupled receptors. , 2000, Molecular pharmacology.
[282] Motonao Nakamura,et al. Functional coupling of adenosine A2a receptor to inhibition of the mitogen-activated protein kinase cascade in Chinese hamster ovary cells. , 1996, The Biochemical journal.
[283] H. Carswell,et al. Kainate‐Evoked Release of Adenosine from the Hippocampus of the Anaesthetised Rat: Possible Involvement of Free Radicals , 1997, Journal of neurochemistry.
[284] H. Vapaatalo,et al. Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA). , 1975, Arzneimittel-Forschung.
[285] S. Rivkees,et al. Characterization of the Murine A1 Adenosine Receptor Promoter: Potent Regulation by GATA-4 and Nkx2.5 , 1999, The Journal of biological chemistry.
[286] I. Lampronti,et al. Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor. , 2000, Bioorganic & medicinal chemistry letters.
[287] C. Kennedy,et al. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation , 1997, nature.
[288] K. Jacobson,et al. Adenosine analogs with covalently attached lipids have enhanced potency at A1‐adenosine receptors , 1987, FEBS letters.
[289] G. Firestein,et al. cDNA cloning and characterization of A3i, an alternatively spliced rat A3 adenosine receptor variant , 1996, FEBS letters.
[290] Taosheng Chen,et al. A2B Adenosine and P2Y2 Receptors Stimulate Mitogen-activated Protein Kinase in Human Embryonic Kidney-293 Cells , 1999, The Journal of Biological Chemistry.
[291] K. Jacobson,et al. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor. , 1994, Molecular pharmacology.
[292] F. Ciruela,et al. Ligand-induced phosphorylation, clustering, and desensitization of A1 adenosine receptors. , 1997, Molecular pharmacology.
[293] B. Fredholm,et al. The adenosine receptor mediated accumulation of cyclic AMP in Jurkat cells is enhanced by a lectin and by phorbol esters. , 1987, Biochemical and biophysical research communications.
[294] P. Svenningsson,et al. Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat , 1998, Neuropharmacology.
[295] H. Zimmermann. Extracellular metabolism of ATP and other nucleotides , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[296] A. Balmforth,et al. Identification of a B 2-bradykinin receptor linked to phospholipase C and inhibition of dopamine stimulated cyclic AMP accumulation in the human astrocytoma cell line D 384 , 2022 .
[297] M. Sitkovsky,et al. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. , 1999, Molecular pharmacology.
[298] P. Svenningsson,et al. Glucocorticoids regulate the expression of adenosine A1 but not A(2A) receptors in rat brain. , 1997, Journal of Pharmacology and Experimental Therapeutics.
[299] E. Jackson,et al. A2B Receptors Mediate Antimitogenesis in Vascular Smooth Muscle Cells , 2000 .
[300] J. Keefer,et al. Targeting of G Protein-coupled Receptors to the Basolateral Surface of Polarized Renal Epithelial Cells Involves Multiple, Non-contiguous Structural Signals* , 1998, The Journal of Biological Chemistry.
[301] B B Fredholm,et al. Modulation of neurotransmission by purine nucleotides and nucleosides. , 1980, Biochemical pharmacology.
[302] K. Fuxe,et al. Adenosine A1 Receptor-mediated Modulation of Dopamine D1 Receptors in Stably Cotransfected Fibroblast Cells* , 1998, The Journal of Biological Chemistry.
[303] U. Ungerstedt,et al. Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre , 1982, Neuroscience Letters.
[304] K. Fuxe,et al. Effect of some phosphodiesterase inhibitors on central dopamine mechanisms. , 1976, European journal of pharmacology.
[305] A. Dana,et al. Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. , 2000, Circulation.
[306] B. Fredholm,et al. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]‐SCH 58261 , 1997, British journal of pharmacology.
[307] M. Jacobson,et al. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. , 2000, The Journal of clinical investigation.
[308] J. Harvey,et al. A Postsynaptic Interaction between Dopamine D1 and NMDA Receptors Promotes Presynaptic Inhibition in the Rat Nucleus Accumbens via Adenosine Release , 1997, The Journal of Neuroscience.
[309] P. Marangos. Adenosinergic approaches to stroke therapeutics. , 1990, Medical hypotheses.
[310] G. Stiles,et al. Separate promoters in the human A1 adenosine receptor gene direct the synthesis of distinct messenger RNAs that regulate receptor abundance. , 1995, Molecular pharmacology.
[311] J. Linden,et al. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. , 2001, Molecular pharmacology.
[312] B. Fredholm,et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. , 1999, Pharmacological reviews.
[313] J. Dickenson,et al. Homologous and heterologous desensitization of histamine H1‐and ATP‐receptors in the smooth muscle cell line, DDT1MF‐2: the role of protein kinase C , 1993, British journal of pharmacology.
[314] J. Linden,et al. Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe. , 1996, Molecular pharmacology.
[315] B B Fredholm,et al. Stimulation of adenosine A1 receptors and bradykinin receptors, which act via different G proteins, synergistically raises inositol 1,4,5-trisphosphate and intracellular free calcium in DDT1 MF-2 smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[316] B. Fredholm,et al. How does adenosine inhibit transmitter release? , 1988, Trends in pharmacological sciences.
[317] M. Akbar,et al. A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release. , 1994, Molecular pharmacology.
[318] E. Marbán,et al. ATP-Sensitive Potassium Channels , 2021, Encyclopedia of Molecular Pharmacology.
[319] E. Hollingsworth,et al. An activator of protein kinase C (phorbol‐12‐myristate‐13‐acetate) augments 2‐chloroadenosine‐elicited accumulation of cyclic AMP in guinea pig cerebral cortical particulate preparations , 1985, FEBS letters.
[320] J. Baldwin,et al. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.
[321] J. Linden,et al. Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum , 2001, The Journal of comparative neurology.
[322] P. Schofield,et al. Cloning, characterisation and chromosomal assignment of the human adenosine A3 receptor (ADORA3) gene 1 GenBank™ accession numbers: L77729 and L77730. 1 , 1997, Neuroscience Research.
[323] P. Svenningsson,et al. Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. , 2000, Molecular pharmacology.
[324] B. Cronstein. Adenosine, an endogenous anti-inflammatory agent. , 1994, Journal of applied physiology.
[325] K. Klotz,et al. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[326] A. Tucker,et al. Cloning and expression of a bovine adenosine A1 receptor cDNA , 1992, FEBS letters.
[327] C. Brown,et al. Adenosine relaxes the aorta by interacting with an A2 receptor and an intracellular site. , 1983, European journal of pharmacology.
[328] J. Dumont,et al. Cloning and functional characterization of a human A1 adenosine receptor. , 1992, Biochemical and biophysical research communications.
[329] T. Nakayama,et al. A T1083C polymorphism in the human adenosine A2a receptor gene is not associated with essential hypertension. , 1998, American journal of hypertension.
[330] J. Linden. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.
[331] G. Ghai,et al. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist. , 1987, The Journal of pharmacology and experimental therapeutics.
[332] G. Kreutzberg,et al. Correlation of 5′-nucleotidase activity and selective transneuronal transfer of adenosine in the hippocampus , 1979, Brain Research.
[333] B. Fredholm,et al. The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum. , 1993, European journal of pharmacology.
[334] K. Ravid,et al. Characterization of the mouse A3 adenosine receptor gene: exon/intron organization and promoter activity. , 1999, Genomics.
[335] A. Green,et al. Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist. , 1987, The Journal of biological chemistry.
[336] M. Danhof,et al. High-performance liquid chromatography of the adenosine A1 agonist N6-cyclopentyladenosine and the A1 antagonist 8-cyclopentyltheophylline and its application in a pharmacokinetic study in rats. , 1993, Journal of chromatography.
[337] T. Dunwiddie,et al. The Role of Cyclic AMP as a Precursor of Extracellular Adenosine in the Rat Hippocampus , 1997, Neuropharmacology.
[338] A. Składanowski,et al. Distinct Roles for Recombinant Cytosolic 5′-Nucleotidase-I and -II in AMP and IMP Catabolism in COS-7 and H9c2 Rat Myoblast Cell Lines* , 2000, The Journal of Biological Chemistry.
[339] R. Einstein,et al. STUDIES ON THE CORONARY DILATOR ACTIONS OF SOME ADENOSINE ANALOGUES , 1974, British journal of pharmacology.
[340] G. Gross,et al. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. , 1993, The American journal of physiology.
[341] E. M. Adler,et al. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.
[342] B. Fredholm,et al. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. , 2000, Molecular pharmacology.
[343] U. Ungerstedt,et al. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia , 1994, Neuroscience.
[344] M. Olah. Identification of A2a Adenosine Receptor Domains Involved in Selective Coupling to GS , 1997, The Journal of Biological Chemistry.
[345] P. Popoli,et al. Effects of SCH 58261, an Adenosine A2A Receptor Antagonist, on Quinpirole-Induced Turning in 6-Hydroxydopamine-Lesioned Rats: Lack of Tolerance after Chronic Caffeine Intake , 2000, Neuropsychopharmacology.
[346] V. Thourani,et al. A(3) adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. , 1999, The American journal of physiology.
[347] B. Lanpher,et al. Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[348] R Rubio,et al. Brain adenosine concentration during hypoxia in rats. , 1981, The American journal of physiology.
[349] M. Williams,et al. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. , 1989, The Journal of pharmacology and experimental therapeutics.
[350] R F Bruns,et al. Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. , 1980, Canadian journal of physiology and pharmacology.
[351] Wyeth Wasserman,et al. Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[352] A. Ullrich,et al. Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.
[353] Localization and functional effects of adenosine A1 receptors on cardiac vagal afferents in adult rats. , 1998, American journal of physiology. Heart and circulatory physiology.
[354] A. Mendonça,et al. Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation , 1995 .
[355] T. Dunwiddie,et al. Activation of Hippocampal Adenosine A3 Receptors Produces a Desensitization of A1 Receptor-Mediated Responses in Rat Hippocampus , 1997, The Journal of Neuroscience.
[356] P. Svenningsson,et al. Adenosine A2A Receptors are Colocalized with and Activate Golf in Rat Striatum , 2000 .
[357] A Sattin,et al. The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. , 1970, Molecular pharmacology.